Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 20.91%1.8B | -10.07%1.47B | 41.91%1.53B | 60.18%5.98B | 36.46%1.79B | -36.96%1.49B | 84.07%1.63B | 231.06%1.08B | -64.38%3.73B | -53.13%1.31B |
| Net income from continuing operations | -56.43%539M | -16.24%949M | 7.78%1.29B | -2.02%4.79B | -10.26%1.23B | -22.74%1.24B | 67.85%1.13B | -4.25%1.2B | -33.39%4.89B | -20.96%1.37B |
| Operating gains losses | 1,200.00%22M | 0.00%-1M | -400.00%-10M | 75.34%-18M | 75.93%-13M | -166.67%-2M | 92.31%-1M | 77.78%-2M | 53.80%-73M | -1,700.00%-54M |
| Depreciation and amortization | 79.33%911M | 4.82%478M | 8.37%531M | 3.99%1.98B | 8.18%529M | 6.95%508M | 0.66%456M | 0.00%490M | 0.53%1.91B | 5.16%489M |
| Deferred tax | -477.36%-200M | --0 | 81.10%-31M | -67.06%-142M | -71.43%44M | 131.55%53M | -400.00%-75M | -192.86%-164M | -10.39%-85M | -45.20%154M |
| Other non cashItems | 32,700.00%328M | -160.00%-13M | -1,000.00%-18M | 32.51%-137M | 12.90%-135M | -97.14%1M | -113.89%-5M | 101.68%2M | -3,960.00%-203M | -761.11%-155M |
| Change In working capital | 163.87%198M | -57.02%52M | 47.64%-233M | 81.67%-495M | 128.48%139M | -175.06%-310M | 148.21%121M | 81.26%-445M | -281.89%-2.7B | -241.45%-488M |
| -Change in receivables | -18.98%444M | 119.40%168M | 98.34%-12M | -638.40%-1.28B | -125.99%-236M | 168.07%548M | -186.75%-866M | -265.60%-722M | 127.49%237M | 97.39%908M |
| -Change in inventory | -152.99%-266M | -18.29%201M | -29.59%-254M | 148.69%335M | 27.42%-217M | 252.12%502M | -41.43%246M | 59.08%-196M | -44.23%-688M | -1,768.75%-299M |
| -Change in payables and accrued expense | 101.47%20M | -142.78%-317M | -93.02%33M | 119.82%446M | 153.97%592M | -187.86%-1.36B | 300.81%741M | 120.28%473M | -179.67%-2.25B | -1,008.08%-1.1B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 20.91%1.8B | -10.07%1.47B | 41.91%1.53B | 60.18%5.98B | 36.46%1.79B | -36.96%1.49B | 84.07%1.63B | 231.06%1.08B | -64.38%3.73B | -53.13%1.31B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0.41%-482M | -3.51%-472M | 21.62%-377M | -7.73%-1.83B | 1.70%-404M | -27.37%-484M | 6.75%-456M | -16.18%-481M | -174.11%-1.69B | 13.11%-411M |
| Net PPE purchase and sale | -3.70%-504M | -2.17%-471M | 19.92%-398M | -4.59%-1.87B | 10.00%-423M | -25.58%-486M | 7.62%-461M | -15.85%-497M | -16.97%-1.79B | 4.47%-470M |
| Net investment purchase and sale | --0 | ---4M | ---- | --0 | --0 | --0 | --0 | ---- | --0 | ---- |
| Net other investing changes | 1,000.00%22M | -40.00%3M | 31.25%21M | -53.85%42M | -67.80%19M | -71.43%2M | -50.00%5M | 6.67%16M | -90.04%91M | 210.53%59M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 0.41%-482M | -3.51%-472M | 21.62%-377M | -7.73%-1.83B | 1.70%-404M | -27.37%-484M | 6.75%-456M | -16.18%-481M | -174.11%-1.69B | 13.11%-411M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -20.09%-1.84B | -12.77%-371M | -28.98%-365M | 17.95%-4.04B | 31.10%-1.9B | 6.47%-1.53B | -25.10%-329M | -4.43%-283M | 40.43%-4.93B | -27.94%-2.75B |
| Net issuance payments of debt | -20.00%-6M | 50.00%-4M | 20.00%-4M | -454.55%-122M | -1,633.33%-104M | 0.00%-5M | -33.33%-8M | 0.00%-5M | 97.85%-22M | 0.00%-6M |
| Net common stock issuance | -21.81%-1.47B | --0 | ---54M | 29.45%-2.68B | 39.99%-1.48B | 10.13%-1.21B | --0 | --0 | 40.58%-3.8B | -27.09%-2.46B |
| Cash dividends paid | -13.66%-366M | -14.33%-367M | -10.43%-307M | -12.24%-1.24B | -10.07%-317M | -10.27%-322M | -24.90%-321M | -4.51%-278M | -29.61%-1.1B | -36.49%-288M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -20.09%-1.84B | -12.77%-371M | -28.98%-365M | 17.95%-4.04B | 31.10%-1.9B | 6.47%-1.53B | -25.10%-329M | -4.43%-283M | 40.43%-4.93B | -27.94%-2.75B |
| Net cash flow | ||||||||||
| Beginning cash position | 18.12%2.39B | 50.00%1.76B | 13.31%979M | -76.95%864M | -45.14%1.49B | -14.98%2.02B | -47.57%1.18B | -76.95%864M | 74.13%3.75B | -24.05%2.72B |
| Current changes in cash | 0.94%-525M | -26.30%622M | 151.60%785M | 103.99%115M | 72.41%-511M | -255.88%-530M | 534.59%844M | 120.72%312M | -280.76%-2.89B | -1,170.52%-1.85B |
| End cash Position | 24.90%1.86B | 18.12%2.39B | 50.00%1.76B | 13.31%979M | 13.31%979M | -45.14%1.49B | -14.98%2.02B | -47.57%1.18B | -76.95%864M | -76.95%864M |
| Free cash from | 29.27%1.29B | -14.90%994M | 94.99%1.13B | 111.08%4.11B | 62.43%1.37B | -49.24%1B | 202.59%1.17B | 146.32%579M | -78.24%1.95B | -63.51%841M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.